A Patient with Non-small-cell Lung Cancer Who Developed Immune-related Pancreatitis After Pembrolizumab Administration, Followed by Immune-related Cholangitis

Authors

Institutions

Publication Details

Journal
Haigan
Published
2025-06-20
DOI
https://doi.org/10.2482/haigan.65.186
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Patient with Non-small-cell Lung Cancer Who Developed Immune-related Pancreatitis After Pembrolizumab Administration, Followed by Immune-related Cholangitis

Hibiki Kanda, Yuko Fukumoto, Yuki Imasato, Kei Sasaki
Haigan
Cancer Immunotherapy and Biomarkers
article

A Patient with Non-small-cell Lung Cancer Who Developed Immune-related Pancreatitis After Pembrolizumab Administration, Followed by Immune-related Cholangitis

Hibiki Kanda, Yuko Fukumoto, Yuki Imasato, Kei Sasaki
article en

Abstract

No abstract available for this paper.
HaiganVol. 65(3)
University Hospital Kyoto Prefectural University of Medicine (JP), Seiko Holdings (Japan) (JP), Seiko (United States) (US)
Good health and well-being
Openalex Percentile: Top 77%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Patient with Non-small-cell Lung Cancer Who Developed Immune-related Pancreatitis After Pembrolizumab Administration, Followed by Immune-related Cholangitis — Hibiki Kanda, Yuko Fukumoto, et al. · Haigan (2025) | TGRS Research Map | TGRS